NCT04536324|CompletedDMC
The Absorption Rate of Subcutaneous Infused Fluid
ABSU
Loading search results
ABSU
Sponsor study identifier
observational
6
1 country
1
Study Start
September 1, 2020
Actual (reported)Primary Completion
November 20, 2020
Actual (reported)Study Completion
November 20, 2020
Actual (reported)The purpose of the study is to examine the rate of absorption of subcutaneous infused fluid in older adults when acutely ill compared to when they are not acutely ill.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 20, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 28, 2020
Actual (reported)September 1, 2020
Actual (reported)September 2, 2020
Actual (reported)November 20, 2020
Actual (reported)November 20, 2020
Actual (reported)The difference in the absorption rate between acutely ill and not acutely ill.
We will compare the absorptions rate of subcutaneous infused fluid when the patients are acutely ill (during admission) and when they are not acutely ill (8 weeks after discharge).
8 weeks after discharge
The absorption rate of subcutaneous infused fluid by count over the infusion site
We will count the activity from the start of infusions until 2 hours after all of the 250 ml have been infused.
The absorption rate of subcutaneous infused fluid by count in the thyroid or by count in blood samples.
We will count the activity from the start of infusions until 2 hours after all of the 250 ml have been infused.
Patients will twice receive a subcutaneous infusion of 250 ml isotonic sodium chloride (NaCl) with 30 MBq Tc-99m pertechnetate mixed in. The patients will receive the first infusion during admission to our geriatric ward (when they are acutely ill) and the second infusion approximately 8 weeks after discharge when they are no longer acutely ill. The subcutaneous access will be placed on the abdomen in the lower left or right quadrant.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients admitted to the local geriatric ward will be screened for eligibility.
Aalborg University Hospital
Aalborg, Denmark
Danielsen MB, Jodal L, Riis J, Karmisholt JS, Valdorsson O, Jorgensen MG, Andersen S. Absorption rate of subcutaneously infused fluid in ill multimorbid older patients. PLoS One. 2022 Oct 10;17(10):e0275783. doi: 10.1371/journal.pone.0275783. eCollection 2022.
Mathias B Danielsen, MD
Aalborg University Hospital
6 participants (actual enrollment reported by the registry).
First Submitted
August 28, 2020
First Posted
September 2, 2020
Study Start
September 1, 2020
Actual (reported)Effect of Different Fluid Ingestion Rate on Post-exercise Rehydration
The correlation between s-albumin and absorption time.
We will count the activity from the start of infusions until 2 hours after all of the 250 ml have been infused.
Contact the study team to confirm eligibility.
Primary Completion
November 20, 2020
Actual (reported)Study Completion
November 20, 2020
Actual (reported)Last Updated
February 4, 2021
Record last verified: 2021-02
All of the individual participant data collected during the trial, after deidentification. Data sets will only be shared when the anonymity of included participants can be insured.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: